Immunome Inc (IMNM) Implied Volatility Current

Tracking IMNM implied volatility helps you identify when options premiums on Immunome Inc are historically cheap or expensive, and where the best trades are hiding. Immunome Inc implied volatility reflects the market's expectation of future price movement: when IMNM IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Immunome Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IMNM, tracking metrics like IMNM IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IMNM signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IMNM implied volatility sits today versus where it has been. Our scanner ranks Immunome Inc implied volatility against its historical range, surfaces extremes in IMNM IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Immunome Inc IV is rich or cheap — measure it, then act on it.